-transparent.png){kind=logo}
Oestrogen receptor (OR) assay has an essential role in selecting therapy for breast cancer patients, OR status is probably also of prognostic value. The correlation between the size of the primary tumour and OR status was evaluated in 100 women with breast cancer. In 72 post-menopausal patients the OR average level was significantly higher in large primary tumours--T2, T3, when compared to OR levels of T1 tumours. In the 28 pre-menopausal women, this difference was not statistically significant. No correlation between OR level and stage of disease was found. Women presenting with large primary tumours do not necessarily have a poor prognosis.
Related Publications
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
August 1982,
The Australian and New Zealand journal of surgery,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
June 1985,
British journal of cancer,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
December 1983,
Clinical oncology,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
January 1985,
East African medical journal,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
January 1991,
European journal of cancer (Oxford, England : 1990),
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
April 1986,
Irish medical journal,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
June 1986,
Journal of steroid biochemistry,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
June 1997,
BMJ (Clinical research ed.),
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
April 1980,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
O Kaplan, and
Y Skornick, and
F Greif, and
Y Klausner, and
R R Rozin
December 1988,
British journal of cancer,
